#
Aripiprazole lauroxil Intramuscular
  • Drugs A to Z
  • Aripiprazole lauroxil (Intramuscular)

Aripiprazole lauroxil (Intramuscular)

Medically reviewed by Drugs.com. Last updated on Apr 14, 2022.

Intramuscular route(Suspension, Extended Release)

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole lauroxil is not approved for the treatment of patients with dementia-related psychosis .

Commonly used brand name(s)

In the U.S.

  • Aristada
  • Aristada Initio

Available Dosage Forms:

  • Suspension, Extended Release

Therapeutic Class: Antipsychotic

Uses for aripiprazole lauroxil

Aripiprazole lauroxil extended-release injection is used to treat schizophrenia (a mental disorder). It works in the brain to change how certain chemicals affect patients. Aripiprazole is an antipsychotic agent.

Aripiprazole lauroxil is available only with your doctor's prescription.

Before using aripiprazole lauroxil

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For aripiprazole lauroxil, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to aripiprazole lauroxil or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of aripiprazole lauroxil injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies have not been performed on the relationship of age to the effects of aripiprazole lauroxil in the geriatric population. Safety and efficacy have not been established. Aripiprazole lauroxil should not be used to treat behavioral problems in elderly patients who have dementia or Alzheimer disease.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the p..